Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew G. who wrote (223)	1/11/1998 4:19:00 PM
From: Michael Anthony	Read Replies (3) \| Respond to of 1321

Thanks for the link. I'll look into it. FWIW, I believe phase 3 clinical trials for ARMD has already started. I would suspect aproval is going to be later this year or early next year. However, with the FDA recently accelerating the approval process for many therapies, it could be sooner. The success rates so far are fantastic from what I have heard. I plan to connect myself directly with some folks involved in the actual clinical trials very soon to get their first hand opinions and other details of how it works and what the patient goes through. I'll also be interested in the screening process and what criteria is needed before treatment is indicated. I expect to attend a seminar in middle February at which one of the speakers is directly involved with the trials. I'll post what I find out when I find out what I find out :)